| Literature DB >> 35395932 |
Nicolas Arnaud1, Johanna Weymann2, Kirsten Lochbühler3, Benjamin Pietsch4, Monika Rossa3, Ludwig Kraus3, Rainer Thomasius2, Reiner Hanewinkel4, Matthis Morgenstern4.
Abstract
BACKGROUND: Substance-related and addictive disorders are among the most common mental disorders in adolescence and young adulthood. Vocational school students are a risk group for problematic substance use and addictive behavior. However, the availability of evidence-based prevention concepts and programs is underdeveloped in the vocational school setting. METHODS/Entities:
Keywords: Abstinence; Cluster-randomized controlled trial; Internet-related problems; Prevention; Substance use; Vocational students; Voluntary commitment
Mesh:
Year: 2022 PMID: 35395932 PMCID: PMC8990496 DOI: 10.1186/s13063-022-06231-x
Source DB: PubMed Journal: Trials ISSN: 1745-6215 Impact factor: 2.279
Fig. 1Consolidated Standards for Reporting Trials (CONSORT) diagram: study design and participant flow
Fig. 2Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) diagram detailing the trial activities and measures and their timing
| Title {1} | Effectiveness of an app-based intervention to reduce substance use, gambling, and digital media use in vocational school students: study protocol for a randomized controlled trial |
| Trial registration {2a and 2b}. | Trial registration number DRKS00023788. Registered on 20 January 2021. |
| Protocol version {3} | The current protocol version is version 1.0, dated from 02 December 2021. |
| Funding {4} | The trial is funded by the Federal Ministry of Health Germany (BMG, grant number: ZMVI1-2519DSM216). The funding period is from 01 August 2019 to 31 December 2022. The funding source has no role in the design of this study and will not have any role in its execution, analyses, interpretation of the data, or decision to submit results. |
| Author details {5a} | NA, JW, RT: German Centre for Addiction Research in Childhood and Adolescence at University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; KL, MR, LK: IFT Institut für Therapieforschung München, Germany; MM, BP, RH: Institute for Therapy and Health Research, IFT-Nord. |
| Name and contact information for the trial sponsor {5b} | Institute for Therapy and Health Research, IFT-Nord, Kiel, GermanyTrial’s principal investigator: Reiner Hanewinkel, hanewinkel@ift-nord.de; scientific coordinator: Matthis Morgenstern, morgenstern@ift-nord.de. |
| Role of sponsor {5c} | The sponsor is non-commercial. The sponsor ensures quality management, qualified and trained personnel, study protocol compliance, and submission of relevant study documents to the ethics committee and regulatory authorities. He supports the study with trial unit facilities and study personnel. |